Amelioration of insulin resistance in rat cells by Astragalus polysaccharides and associated mechanisms

Liu,Hongzhi; Bai,Jianmei; Weng,Xiaogang; Wang,Tao; Li,Meijuan

doi:10.3892/etm.2014.1626

Amelioration of insulin resistance in rat cells by Astragalus polysaccharides and associated mechanisms

Authors:
- Hongzhi Liu
- Jianmei Bai
- Xiaogang Weng
- Tao Wang
- Meijuan Li
View Affiliations

Affiliations: Department of Internal Medicine, Tianjin Prevention and Treatment Center of Occupational Diseases, Tianjin 300011, P.R. China, Department of Internal Medicine, Xinxing Hospital of Tianjin, Tianjin 300070, P.R. China, Department of Endocrinology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China
Published online on: March 18, 2014 https://doi.org/10.3892/etm.2014.1626
Pages: 1599-1604

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the function of Astragalus polysaccharides (APS) in ameliorating insulin resistance (IR) in rat cells and to elucidate the associated mechanisms. Fully differentiated, induced 3T3‑L1 rat adipocytes were divided into a control group and three intervention groups. The intervention groups were incubated in media containing 0.001, 0.1 and 10 µg/µl APS, respectively, for 48 h. Following treatment, levels of interleukin (IL)‑6 and adiponectin secreted by the cultured adipocytes were measured using enzyme‑linked immunosorbent assay. Levels of adiponectin secreted by the 3T3‑L1 adipocytes in the moderate‑concentration intervention group were significantly increased compared with those in the control group (P<0.05), whereas levels of adiponectin secreted by the 3T3‑L1 adipocytes in the low- and high‑concentration intervention groups were decreased compared with those in the control group (P<0.05 and P>0.05, respectively). Levels of IL‑6 secreted by the 3T3‑L1 adipocytes in the three intervention groups were lower than those in the control group (P>0.05, P<0.05 and P<0.05 for the low‑ moderate‑ and high‑concentration intervention groups, respectively), and demonstrated APS dose‑dependence. The results indicate that APS are capable of increasing adiponectin secretion and reducing IL‑6 secretion by 3T3‑L1 rat adipocytes in a dose‑dependent manner. These findings may identify a potential mechanism for ameliorating IR using APS.

View Figures

View References

1	Ferrannini E, Balkau B, Coppack SW, et al; RISC Investigators. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab. 92:2885–2892. 2007. View Article : Google Scholar : PubMed/NCBI
2	Haffner SM, D’Agostino R Jr, Mykkänen L, et al: Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 22:562–568. 1999. View Article : Google Scholar : PubMed/NCBI
3	Tanti JF, Ceppo F, Jager J and Berthou F: Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol (Lausanne). 3:1812013.PubMed/NCBI
4	Fresno M, Alvarez R and Cuesta N: Toll-like receptors, inflammation, metabolism and obesity. Arch Physiol Biochem. 117:151–164. 2011. View Article : Google Scholar : PubMed/NCBI
5	Zoico E, Di Francesco V, Olioso D, et al: In vitro aging of 3T3-L1 mouse adipocytes leads to altered metabolism and response to inflammation. Biogerontology. 11:111–122. 2010. View Article : Google Scholar : PubMed/NCBI
6	Weng XG, Bai LW, Liu HZ, Wang T and Chen LL: Effects of Astragalus polysaccharides on expression of adiponectin in 3T3-L1 adipocytes. J Appl Clin Pediatr. 24:1598–1600. 2009.(In Chinese).
7	Zhao M, Zhang ZF, Ding Y, Wang JB and Li Y: Astragalus polysaccharide improves palmitate-induced insulin resistance by inhibiting PTP1B and NF-κB in C2C12 myotubes. Molecules. 17:7083–7092. 2012.PubMed/NCBI
8	Zhang JB: Medical Cell Biology experiments guidance and Exercises. Beijing: People’s Medical Publishing House; 2005, pp. 107
9	Ramírez-Zacarías JL1, Castro-Muñozledo F and Kuri-Harcuch W: Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 97:493–497. 1992.PubMed/NCBI
10	Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM and Ford ES: Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes. 53:1195–1200. 2004. View Article : Google Scholar : PubMed/NCBI
11	Gao XM: Traditional Chinese Pharmacology. Beijing: Traditional Chinese Medicine Publishing House; 2011, pp. 428
12	Wu M and Tan R: Advance in study on astragalus polysaccharide. Journal of North Sichuan Medical College. 28:17–22. 2013.(In Chinese).
13	Cui J, Panse S and Falkner B: The role of adiponectin in metabolic and vascular disease: a review. Clin Nephrol. 75:26–33. 2011.PubMed/NCBI
14	Phillips SA and Kung JT: Mechanisms of adiponectin regulation and use as a pharmacological target. Curr Opin Pharmacol. 10:676–683. 2010. View Article : Google Scholar : PubMed/NCBI
15	Lavrenko AV, Shlykova OA, Kutsenko LA, Mamontova TV and Kaĭdashev IP: Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-gamma2 gene polymorphism. Ter Arkh. 84:35–40. 2012.(In Russian).
16	Lefils-Lacourtablaise J, Socorro M, Géloën A, et al: The eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanism. PLoS One. 8:e639972013.PubMed/NCBI
17	Kubota N, Terauchi Y, Kubota T, et al: Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem. 281:8748–8755. 2006. View Article : Google Scholar : PubMed/NCBI
18	Tishinsky JM, Ma DW and Robinson LE: Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARγ-dependent manner in human adipocytes. Obesity (Silver Spring). 19:262–268. 2011.PubMed/NCBI
19	Bak EJ, Park HG, Kim JM, Kim JM, Yoo YJ and Cha JH: Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes. Int J Obes (Lond). 34:250–260. 2010. View Article : Google Scholar : PubMed/NCBI
20	Liu M, Ouyang JP, Wu K, et al: Effect of Astragalus polysaccharide on Ser phosphorylation of protein kinase B in skeletal muscle of KKAy mice. Medical Journal of Wuhan University. 27:135–139. 2006.(In Chinese).
21	Gao P, Li Q, Sun YZ and Zhang JC: Continuously activated Akt inhibits adiponectin secretion in 3T3-L1 adipocytes. Chinese Journal of Diabetes. 14:142–143. 1452006.(In Chinese).
22	Goldberg RB: Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 94:3171–3182. 2009. View Article : Google Scholar : PubMed/NCBI
23	Phillips CM and Perry IJ: Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab. 98:E1610–E1619. 2013. View Article : Google Scholar : PubMed/NCBI
24	Wei SS and Liang DD: The effect of exercises on TNF-alpha, IL-6 and adiponectin in different fat diet rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 29:280–282. 2013.(In Chinese).
25	Conroy SM, Chai W, Lim U, Franke AA, Cooney RV and Maskarinec G: Leptin, adiponectin, and obesity among Caucasian and Asian women. Mediators Inflamm. 2011:2535802011. View Article : Google Scholar : PubMed/NCBI
26	Rotter V, Nagaev I and Smith U: Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem. 278:45777–45784. 2003. View Article : Google Scholar
27	Liu HF, Ren YH, Han ZX, et al: Effect of astragalus polysaccharides on insulin resistance and gene expression of GLUT4 in type 2 diabetes mellitus rats. Chinese Journal of Gerontology. 31:3988–3989. 2011.(In Chinese).
28	Xu Y, Wang BH, LI K, et al: Insulin-sensitization of Astragalus polysaccharide and its effect on protein tyrosine phosphatase 1B. Medical Journal of Wuhan University. 3:288–291. 2010.(In Chinese).
29	Hu YQ, Li J, Liu J, Ou-Yang JP and Song J: APS improves free fatty acid metabolism by activating AMPK and promoting translocation of FAT/CD36 in C2C12 myoblasts. Chin J Pathophysiol. 29:637–640. 2013.(In Chinese).
30	Liang LJ, Wang HX, Sun XF, et al: Astragalus polysaccharides ameliorate hypertrophy of cardiomyocytes induced by tumor necrosis factor-α via TLR4/NF-κB signaling pathway. Chin J Pharmacol Toxicol. 27:168–173. 2013.(In Chinese).